个性化文献订阅>期刊> Current Pharmaceutical Design
 

Pharmacology of Sigma (sigma) Receptor Ligands from a Behavioral Perspective

  作者 Skuza, G  
  选自 期刊  Current Pharmaceutical Design;  卷期  2012年18-7;  页码  863-874  
  关联知识点  
 

[摘要]The sigma receptors are regarded as unique binding sites, distinct from opiate and PCP receptors and implicated in higher brain function. They were classified into sigma(1) and sigma(2) subtypes, the former was cloned from rodent and human tissues while the latter has not yet been fully characterized. Although the precise mechanism of the functional response of sigma receptors is still uncertain, it has been accepted that they can modulate a number of central neurotransmitter systems, including glutamate/NMDA, serotonergic, dopaminergic, noradrenergic routes, as well as some other signaling pathways (e.g. neurotrophin and growth factor signaling) which are seemingly important for the brain function. In accordance with their modulatory role, sigma receptor ligands have been proposed to be useful in several therapeutic areas such as schizophrenia, depression and anxiety, amnesic and cognitive deficits, drugs of abuse. The present review summarizes the findings related to the pharmacological effects and potential activity of sigma receptor ligands from behavioral models predictive of some neuropsychiatric disorders.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内